NOTARBARTOLO DI VILLAROSA, Monica
 Distribuzione geografica
Continente #
NA - Nord America 6.761
EU - Europa 4.320
AS - Asia 3.408
SA - Sud America 584
AF - Africa 117
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.197
Nazione #
US - Stati Uniti d'America 6.642
SG - Singapore 1.221
IT - Italia 1.164
RU - Federazione Russa 1.004
CN - Cina 857
BR - Brasile 480
FI - Finlandia 470
HK - Hong Kong 363
UA - Ucraina 350
VN - Vietnam 328
DE - Germania 324
PL - Polonia 205
GB - Regno Unito 180
IE - Irlanda 172
FR - Francia 171
JP - Giappone 117
IN - India 102
TR - Turchia 80
SE - Svezia 77
BD - Bangladesh 74
CA - Canada 51
KR - Corea 49
MX - Messico 41
NL - Olanda 39
AR - Argentina 34
IQ - Iraq 32
BE - Belgio 25
ES - Italia 25
MY - Malesia 24
PK - Pakistan 24
AT - Austria 22
BG - Bulgaria 22
MA - Marocco 22
RO - Romania 22
ZA - Sudafrica 22
CI - Costa d'Avorio 19
VE - Venezuela 18
EC - Ecuador 17
EG - Egitto 15
CL - Cile 13
ID - Indonesia 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
IR - Iran 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
LB - Libano 11
CH - Svizzera 9
HN - Honduras 9
PH - Filippine 8
CZ - Repubblica Ceca 7
DZ - Algeria 7
LT - Lituania 7
SY - Repubblica araba siriana 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
AU - Australia 5
BO - Bolivia 5
CO - Colombia 5
JM - Giamaica 5
JO - Giordania 5
NP - Nepal 5
PY - Paraguay 5
UY - Uruguay 5
BH - Bahrain 4
ET - Etiopia 4
GR - Grecia 4
KE - Kenya 4
MT - Malta 4
OM - Oman 4
TW - Taiwan 4
AL - Albania 3
GE - Georgia 3
GT - Guatemala 3
PA - Panama 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
GA - Gabon 2
GH - Ghana 2
HU - Ungheria 2
IL - Israele 2
LY - Libia 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
Totale 15.189
Città #
Ashburn 853
Singapore 812
Fairfield 633
Houston 387
Chandler 380
Woodbridge 364
Palermo 359
Hong Kong 347
San Jose 341
Wilmington 271
Ann Arbor 269
Seattle 231
Cambridge 199
Jacksonville 187
Zgierz 183
Moscow 181
Dublin 164
Beijing 146
Santa Clara 139
Des Moines 135
Medford 128
Council Bluffs 118
Los Angeles 117
Tokyo 112
Ho Chi Minh City 110
New York 100
Frankfurt am Main 99
Dallas 90
Lauterbourg 85
Nanjing 84
Boardman 81
Princeton 79
Hanoi 74
Helsinki 70
The Dalles 67
Altamura 62
Hefei 61
Tulsa 52
Lawrence 50
San Diego 50
Buffalo 47
São Paulo 45
Dearborn 43
Rome 39
Milan 38
London 30
Shenyang 30
Izmir 29
Hebei 27
Venice 27
Chicago 25
Nanchang 25
Changsha 24
Atlanta 23
Nuremberg 23
Bremen 22
Brussels 22
Columbus 22
Ludwigshafen am Rhein 22
Memphis 21
Brooklyn 20
Shanghai 20
Abidjan 19
Sofia 19
Orem 17
Catania 16
Falls Church 16
Kuala Lumpur 16
Ningbo 16
Phoenix 16
San Paolo di Civitate 16
Denver 15
Messina 15
Verona 15
Warsaw 15
Zhengzhou 15
Montreal 14
Rio de Janeiro 14
Seongnam 14
Tianjin 14
City of London 13
Jinan 13
Salerno 13
Belo Horizonte 12
Brasília 12
Hangzhou 12
Munich 12
Naples 12
Amsterdam 11
Auburn Hills 11
Guangzhou 11
Haiphong 11
Jiaxing 11
Johannesburg 11
Manchester 11
Stockholm 11
Baghdad 10
Chennai 10
Da Nang 10
Kumar 10
Totale 9.403
Nome #
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION 314
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 294
Targeting Multiple Myeloma with natural polyphenols 277
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 275
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 264
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 252
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 248
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 246
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 242
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 242
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 242
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 241
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 233
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 226
Expression of the IAPs in multidrug resistant tumor cells 225
USE OF HERBAL REMEDIES AMONG CANCER AND TRANSPLANT PATIENTS IN THE TOWN OF PALERMO, SICILY 218
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 213
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 210
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 209
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 206
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 205
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 204
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 202
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 195
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 195
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 192
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 191
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 185
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 185
Unusual high dose of tacrolimus in liver transplant patient, a case report. 183
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 182
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 182
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 181
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 176
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 176
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis 175
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 175
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 174
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 173
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 168
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 168
null 164
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 163
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 163
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 162
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 160
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 160
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 159
Use of herbal products among cancer and transplanted patients in the town of Palermo,Sicily. 158
Bioactive triterpenes of protium heptaphyllum gum resin extract display cholesterol-lowering potential 155
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 154
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 154
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 152
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 151
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance 146
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression. 146
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth 146
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 146
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 144
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 140
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 140
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 140
Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines 139
Carrier capability of halloysite nanotubes for the intracellular delivery of antisense PNA targeting mRNA of neuroglobin gene 138
NF-κB is a potential pharmacological target in triple negative breast cancers. 135
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 132
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 131
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 130
Nanocarrier based on halloysite and fluorescent probe for intracellular delivery of peptide nucleic acids 129
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 124
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 122
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 122
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models 118
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 118
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin 117
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 116
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds 115
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 115
Expression of HIP/PAP mRNA in Human Hepatoma Cell Lines 114
Prostaglandin E2 receptors and COX enxymes in human hepatocellular carcinoma: role in the regulation of cell growth 111
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 110
Cancer therapy and treatments during COVID-19 era 110
Ihnibitor of Apoptosis Proteins (IAPs) as a new possible therapeutic targets in hepatocellular cancer. 109
Exploring the cellular uptake of hectorite clay mineral and its drug carrier capabilities 108
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 107
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 106
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 105
Comparison of Synthetic Pathways for Obtaining Fluorescent Nanomaterials Based on Halloysite and Carbon Dots for Potential Biological Sensing 103
Curcumin and doxorubicin encapsulated in biocompatible clay‐based nanomaterial: A strategy to overcome multidrug resistance 103
Recovery of Bioactive Compounds from Marine Organisms: Focus on the Future Perspectives for Pharmacological, Biomedical and Regenerative Medicine Applications of Marine Collagen 97
Supramolecular Association of Halochromic Switches and Halloysite Nanotubes in Fluorescent Nanoprobes for Tumor Detection 91
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 87
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 71
Design of innovative and low-cost dopamine-biotin conjugate sensor for the efficient detection of protein and cancer cells 67
null 67
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 33
Totale 15.647
Categoria #
all - tutte 52.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 0 0 0 0 0 0 90
2021/20221.070 49 222 30 21 44 28 74 40 98 166 90 208
2022/20231.271 134 214 26 145 158 203 101 80 125 10 60 15
2023/2024712 39 87 53 31 44 131 53 49 14 40 43 128
2024/20252.087 43 158 113 200 125 99 202 141 177 199 233 397
2025/20265.861 420 208 356 481 536 908 834 595 422 769 262 70
Totale 15.647